Peak Effect of Monoferric (Ferric Derisomaltose)
Serum ferritin peaks approximately 7 days after an intravenous dose of Monoferric and slowly returns to stable levels after about 4 weeks. 1
Pharmacodynamic Timeline
The peak pharmacodynamic effect of Monoferric follows a predictable temporal pattern:
Serum ferritin concentration reaches its maximum at approximately 7 days post-infusion, then gradually declines to stable baseline levels over the subsequent 3 weeks (total of 4 weeks from administration). 1
Hemoglobin response becomes clinically apparent within 4–8 weeks, with an expected rise of 1–2 g/dL during this interval. 2
Serum iron pharmacokinetics show that total iron (derisomaltose-bound plus transferrin-bound) reaches maximum concentration (Cmax) of 408 μg/mL after a 1000 mg dose, with a mean half-life of 27 hours. 1
Clinical Monitoring Implications
Do not check iron studies within the first 4 weeks after infusion because circulating iron causes spuriously elevated laboratory values that do not reflect true iron stores. 2, 3
Optimal timing for laboratory reassessment is 4–8 weeks post-infusion, when ferritin has stabilized and hemoglobin response can be accurately assessed. 2, 4
At the 4–8 week visit, evaluate:
Practical Considerations
The 7-day ferritin peak represents the pharmacodynamic marker of iron delivery to storage sites, while the 4–8 week hemoglobin rise represents the therapeutic endpoint of erythropoiesis. 1, 2
Single infusion is sufficient when the underlying cause of iron deficiency has been eliminated. 2
Repeat dosing decisions should be based on 4–8 week laboratory results, not on a fixed schedule. 2
The elimination half-life of 27 hours for serum total iron explains why ferritin remains elevated for several weeks before returning to stable levels. 1